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Sickle cell disease (SCD) is a prevalent genetic disorder involving red blood cells. SCD is a 
multisystem disease and is connected to various severe medical complications, including 
debilitating pain. Though pain and inflammation have been connected to adverse childhood 
experiences (ACEs) in other populations, no prior work has investigated ACEs within a SCD 
population. The current study examined the prevalence of ACEs as well as the association of 
ACEs, inflammation, and pain in a sample of youth and young adults with SCD. Utilizing the 
biopsychosocial model of pain, I examined individual and cumulative ACEs as possible factors 
relating to inflammation, pain severity and pain frequency. Self-report measures of ACEs, pain 
severity and pain frequency were completed by a sample of adolescents and young adults with 
SCD (N= 21; mean age = 17.57 years). Further, within the overall sample, 14 participants 
reported pain and 7 participants had C-reactive protein (CRP) reports. CRP, an inflammatory 
biomarker was collected via blood samples drawn from routine clinic visits. Approximately half 
of the current sample reported exposure to at least one ACE, suggesting a high prevalence of 
ACE exposure within a youth SCD population. Cumulative ACEs did not relate to inflammation 
or pain. However, our findings do suggest that inflammation and pain outcomes are associated 
with individual ACE types, specifically financial hardship, racial discrimination, and divorce, 
though not always in the direction hypothesized. The study findings support the importance of 
taking into consideration the differential impact of different individual ACEs and their 







 Sickle cell disease (SCD) is a prevalent genetic disorder involving red blood cells that is 
a multisystem disease and is connected progressive organ damage (Rees, Williams, & Gladwin, 
2010). SCD is particularly prevalent in people of African descent, with one in 400 babies in the 
United States being born with the disease (Lorey, Arnopp, & Cunningham, 1996). Globally, 
around 275,000 newborns are born every year with SCD, with around 85% of births occurring in 
Africa (Aygun & Odame, 2012). An individual diagnosed with sickle cell may experience 
several complications, including but not limited to, acute pain, chronic pain, infection, 
neurological complications, acute chest syndrome, pulmonary hypertension, and heart disease 
(Rees et al., 2010). Complications associated with SCD have significant negative impacts on the 
lives of youth and young adults with the disease. Research has shown that individuals with SCD 
are at high risk for poor health outcomes, poor quality of life, and early mortality (Toledo, 
Guedes, Alpoim, Rios, & Pinheiro, 2019).  
A common complication in youth and adults with SCD is the experience of pain. Pain has 
been primarily linked to vaso-occlusive crisis (VOC). A VOC involves sickled cells promoting 
micro-and macro-vascular occlusions (e.g., blockages of blood vessel) (Schiavenato & Alvarez, 
2013). These blockages cause tissue damage and irritation, which is then associated with severe, 
acute pain episodes. Around 95% of hospital admissions for individuals with SCD are due to 
complications involving acute pain episodes (Ballas, Gupta, & Adams-Graves, 2012).  
The biopsychosocial model of pain proposes that pain experiences are based on the 
interplay of biological factors (e.g., neuroendocrine factors, genetics, inflammation), 
psychological factors (e.g., positive and negative affect, pain catastrophizing) and social factors 
(e.g., family and peer environment) (Schlenz, Schatz, & Roberts, 2016; Taylor, Stotts, 
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Humphreys, Treadwell, & Miaskowski, 2013). The model proposes that to understand pain 
comprehensively, one must take into account the individual and interactive ways these factors 
may impact how pain is experienced (Gatchel, Peng, Peters, Fuchs, & Turk, 2007). The 
biopsychosocial model has been applied to understanding pain in youth and young adults with 
SCD (Crosby, Quinn, & Kalinyak, 2015; Schatz et al., 2015; Schlenz et al., 2016; Taylor et al., 
2013), with findings linking a range of biological (e.g., SCD genotype) and psychosocial (e.g., 
negative and positive affect, stress) factors to the pain experiences of individuals with SCD. In 
other populations, there is preliminary evidence linking adverse childhood experiences (ACEs) 
to pain experiences (Drevin et al., 2015; E. S. Nelson, Simons, & Logan, 2018; Sachs‐Ericsson, 
Sheffler, Stanley, Piazza, & Preacher, 2017; Stensland, Dyb, Thoresen, Wentzel-Larsen, & 
Zwart, 2013; You, Albu, Lisenbardt, & Meagher, 2019). However, there is currently no research 
exploring ACES in individuals with SCD or the relationship ACEs and pain experiences in 
individuals within the population. In addition, ACE exposure has been linked to elevated 
inflammation in other populations, (A. Danese et al., 2009; Gouin, Caldwell, Woods, & 
Malarkey, 2017). Inflammation has been associated with worse SCD pain. However, no prior 
research has examined ACEs association with inflammation in individuals with SCD.    
The purpose of the current study is to examine the prevalence of ACEs exposure in 
adolescents and young adults with SCD, and the relationships between ACEs, pain, and 
inflammation in this population. The following sections review the literature on ACEs, and the 
possible link between ACEs and SCD pain. Then followed by a section on the discussion of 





Adverse Childhood Experiences 
 ACEs are a collection of traumatic events that occur in childhood (ages 0 to 17 years) that 
have been connected to various poor outcomes, such as the development or exacerbation of 
chronic health conditions and overall low quality of life (Felitti et al., 1998). They include 
experiences such as abuse, neglect, or household dysfunction. The original ACE questionnaire 
contained seven types of childhood experiences consisting of three categories of childhood abuse 
(psychological abuse, physical abuse, sexual abuse), and four categories of household 
dysfunction (exposure to substance abuse, mental illness, violent treatment of mother, and 
criminal behavior). Since then, the list of ACEs has expanded to include various other factors, 
such as neighborhood violence, homelessness, and bullying (C. D. Bethell et al., 2017; 
Finkelhor, Shattuck, Turner, & Hamby, 2013). For example, a task force that consisted of health 
care providers, researchers, funders, and organizations in Philadelphia proposed that ACEs 
assessment should be expanded to include community-based stressors (e.g., witnessing violence, 
experiencing discrimination/racism, and experiencing bullying) that significantly contribute to 
poorer outcomes (Pachter, Lieberman, Bloom, & Fein, 2017). The first assessment of ACEs was 
the CDC-Kaiser Permanente Study, which collected data from around 10,000 adults and included 
adversities only relating to household dysfunction. The results revealed that over half the 
respondents (52%) experienced at least one ACE and 6.2% experienced four or more ACES 
(Felitti et al., 1998). Since the time of that study, a plethora of research has been done linking 
ACEs to poor health outcomes using adult retrospective reports (Hughes et al., 2017; Kalmakis 
& Chandler, 2015).  
Studies also have assessed ACEs in pediatric populations, and findings have linked 
exposure to ACES reported during childhood to children’s poor health and academic outcomes 
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(C. Bethell, Davis, MB, Gombojav, N, Stumbo, S Poweers, K., 2017; Burke, Hellman, Scott, 
Weems, & Carrion, 2011; Jimenez, Wade, Lin, Morrow, & Reichman, 2016; Liming & Grube, 
2018). For example, the National Survey of Children’s Health (NSCH) started collecting data on 
ACES for children aged 0 to 17 years around the United States using the nine category NSCH-
ACE scale in its 2011/2012 survey (C. D. Bethell et al., 2017). Data collection for this study is 
completed via surveys administered via mail and internet, and all years where data has been 
collected represent a randomly selected nationwide sample. Data from the 2012 survey indicated 
that ACE exposure reported during childhood is negatively related to children’s development as 
well as their physical and mental health (C. Bethell, Newacheck, Hawes, & Halfon, 2014). For 
example, children who were exposed to at least one ACE had lower rates of school engagement 
and higher rates of chronic disease. The nationwide survey was again completed in 2016, and 
results indicated that in the subgroup of children aged 3 to 5 years, three in four children who 
were exposed to at least one ACE had been expelled from school (C. Bethell, Davis, MB, 
Gombojav, N, Stumbo, S Poweers, K., 2017). Further, children exposed to two or more ACEs 
were over four times more likely to exhibit social and emotional problems compared to those 
who were not exposed to ACEs.  
These findings are consistent with a review focused on exploring exposure to ACEs 
during early childhood (i.e., prior to the age of 6 years) and subsequent biopsychosocial 
outcomes (Liming & Grube, 2018). The review found a total of five studies that examined early 
childhood exposure to ACEs. Results revealed that in four of the five studies, there was 
significant evidence of a dose-response in relation to cumulative ACE exposure, behavioral 
issues, and physical health outcomes (i.e., more ACES leading to worse behavioral and physical 
outcomes). Interestingly, the authors indicated they chose a specific developmental period of 
 
9 
early childhood (ages 0 through 6) because it represents a time of increased vulnerability to the 
influence of external factors on development. The authors were interested in how exposure to 
adverse experiences during early childhood would affect brain structure and functioning as well 
as the overall development of health throughout the lifespan. This review highlighted the 
importance of taking into account developmental periods when examining the effects of 
exposure of ACEs on health. 
 ACEs are proposed to be linked to poor health outcomes through their disruption of the 
development of a broad range of biological systems, including the central nervous, endocrine, 
and immune systems (Berens, Jensen, & Nelson, 2017). For example, the brain continues to 
undergo structural development through childhood into early adulthood (Mills et al., 2016). 
Normative neurodevelopment allows for the growth of complex systems linked to advanced 
thought processes and the ability to adapt to environmental changes (e.g., new experiences and 
situations; (Berens et al., 2017)). There has been extensive literature that has linked early life 
adversity with variation in brain structure and functioning, such as negative effects on memory, 
learning, and emotional regulation. For the neuroendocrine system, early adversity has been 
linked to dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis 
develops from the neonatal period up through adolescence (Kate Ryan Kuhlman, Chiang, Horn, 
& Bower, 2017). It is responsible for maintaining homeostasis (i.e., internal stability and 
balance) and supports adaption to environmental stressors. Dysregulation of this system predicts 
the development of chronic illnesses, such as cardiovascular, psychiatric and metabolic related 
diseases (Berens et al., 2017). Additionally, early adversity has been linked to chronic 
inflammation and overall immune dysregulation into adulthood (Fagundes, Glaser, & Kiecolt-
Glaser, 2013). Dysregulation of the immune system and chronic inflammation has been linked to 
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a variety of poor health outcomes, such as cancer (Michael et al., 2006), age-related diseases (A. 
Danese et al., 2009), neurodevelopmental changes (Nusslock & Miller, 2016), and pain (Fabien, 
Mauro, & Stephen, 2005). 
Of note, many biological systems, such as the HPA axis and central nervous system, are 
undergoing critical advancements during adolescence and early adulthood (Kate Ryan Kuhlman 
et al., 2017; Mills et al., 2016). Thus, these developmental periods may act as critical periods for 
exploring the link between ACES and health outcomes. Exposure to ACEs prior to or during 
adolescence and young adulthood can promote functional impairments that evolve throughout 
the lifespan. This is especially concerning, as research indicates that by the time a child reaches 
adolescence, a majority of children will have been exposed to at least one adverse experience. 
This is supported by findings from a study of 6,483 adolescent-parent pairs that found 61.8% of 
their sample of adolescents had experienced at least one ACE (McLaughlin et al., 2013). Also, 
the impact of ACEs may be particularly salient during adolescence and emerging adulthood as 
exposure to the ACE is proximal in occurrence.  
In conclusion, childhood adversity is connected to poor health outcomes and behaviors 
and affects normative physiological development across various systems (Berens et al., 2017; 
Kate Ryan Kuhlman et al., 2017). The disruption and dysregulation of the central nervous, 
endocrine, and the immune systems stemming from early adversity are likely biomechanisms 
that link ACEs to poor health outcomes seen in in the literature. Further, the disruption of these 
systems and associated poor outcomes are particularly crucial to examine during critical 
developmental periods, such as adolescence and emerging adulthood.   
The following section will explore how ACEs are currently being measured, with a 
particular focus on ACE assessment during childhood. 
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Assessing ACEs. Many studies focus on measuring ACEs in adult populations (Burke et 
al., 2011). For adult questionnaires, the format is generally to ask participants to answer whether 
they have been exposed to each type of trauma listed during their first 18 years of life. Each yes 
is equivalent to one ACE. For pediatric populations, there is currently a wide range of surveys 
being used in ACE screenings. A literature review (C. D. Bethell et al., 2017) assembled current 
pediatric ACE surveys used in the literature, with an objective of comparing each one to a newly 
created measure, the NSCH-ACE. The review identified ten child-focused ACE measures, with 
the NSCH-ACE included. Each measure had variability in the number of ACEs assessed with a 
range between 6 and 20 items. Additionally, there were only four types of ACEs being evaluated 
that were common across all measures: parental incarceration, domestic violence, household 
alcohol or substance abuse, and household mental illness/suicide. There were no community 
focused ACEs that were included among all assembled measures. All ten measures were 
available in parental report, but only three (i.e., the Center for Youth Wellness, Yale-Vermont 
Adversity Childhood Scale and Children’s Hospital of Philadelphia’s Childhood Adversity 
Questionnaire) had a complementary child report included. Age eight was the youngest age 
assessed in these youth-based measures, with a general age range of 8 to 19 years. All measures 
were found to be adapted from the original CDC/Kaiser ACE study and used a cumulative risk 
scoring methodology.  
The NSCH-ACE was the first pediatric ACEs measure used on a nationally 
representative sample of US children (C. D. Bethell et al., 2017). In addition, the measure has 
been shown to have strong internal validity and reliability, and high acceptability. Internal 
validity was evaluated using confirmatory factor analysis (CFA), which indicated a single item 
factor solution was appropriate. Reliability was evidenced by high item-total correlations. 
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Acceptability was evidenced by calculating the percentage of unknown and missing values for 
each ACE item. The NSCH is a parent report measure for households that include children aged 
0 to 17 years and it contains a total of nine categories based on the original CDC/Kaiser ACES 
study augmented by additional familial and community level ACEs (i.e., parental death, treated 
unfairly because of race/ethnicity, witnessing neighborhood violence). A benefit of the measure 
is the inclusion of community-based factors (i.e. witnessing neighbor violence, treated unfairly 
because of race/ethnicity) which are critical in understanding trauma that a child encounters not 
only at the household level, but also within their community (Pachter et al., 2017).   
There are limitations with the NSCH-ACE measure, many of which are consistent with 
the majority of pediatric ACE measures. One limitation is that there is only a parent report and 
not a complementary child report. Parental reports may be inconsistent with what their child 
would report. For example, false negatives and underreporting could result because a parent is 
unwilling or unable to disclose abuse or maltreatment (Cprek, Williamson, Brase, & Williams, 
2020). Additionally, reporting on some ACEs may promote feelings of intrusiveness and 
discomfort for parents and their children (Finkelhor, 2018). To address this issue, the NSCH-
ACE measure excludes items related to abuse (i.e., sexual, emotional, and physical abuse). These 
ACEs are deemed particularly sensitive due to the extreme severity of the associated trauma to 
these ACEs and how they involve mandatory reporting to law enforcement (Herzog & Schmahl, 
2018). This exclusion, however, limits the association between ACES and outcomes, as physical, 
emotional and sexual abuse have been significantly connected to a variety of poor mental and 
physical health outcomes (Leserman, 2005; Norman et al., 2012; Springer, Sheridan, Kuo, & 
Carnes, 2007). Notably, even with these items excluded, the NSCH-ACE measure has been 
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associated with poor health outcomes in literature (C. Bethell, Davis, MB, Gombojav, N, 
Stumbo, S Poweers, K., 2017; C. D. Bethell et al., 2017).  
In conclusion, exposure to ACEs have been connected to poor outcomes across various 
domains and throughout the lifespan (C. Bethell, Davis, MB, Gombojav, N, Stumbo, S Poweers, 
K., 2017; Burke et al., 2011; Felitti et al., 1998; Hughes et al., 2017; Jimenez et al., 2016; 
Kalmakis & Chandler, 2015). Adolescence and emerging adults are pivotal developmental stages 
for addressing the impact of ACEs to mitigate the consequences as people age.  Upon reviewing 
literature, the high prevalence of ACEs and the numerous associated health outcomes raises 
concern. With exposure to adversity disrupting physiological development, it is critical to 
understand the possible influence of ACEs on disease symptoms for youth and young adults with 
chronic illnesses, such as pain. The following sections present information on pain in youth and 
young adults with, and then discuss the existing literature on ACEs, inflammation, and SCD 
pain.  
Youth and Young Adult SCD Pain 
 Pain experienced by youth and young adults with SCD is a significant complication (Sil 
(S. Sil, L. L. Cohen, & C. Dampier, 2016; Smith et al., 2008; William et al., 2013). As 
mentioned previously, youth and young adults with SCD often experience acute severe pain 
episodes (Schiavenato & Alvarez, 2013; Smith et al., 2008). These episodes can vary in location, 
intensity, and duration. One study asked 46 youth and young adults aged 8 to 21 years with SCD 
and their parents how many pain episodes the individual with SCD had experienced in the past 
12 months (Schatz et al., 2015). Parents reported their children had an average of 4.3 episodes 
that resulted in an inpatient and/or ER visit and 14.5 episodes managed at home over a 12-month 
period. Youth and young adults reported an average of 4.6 episodes that required an inpatient 
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and/or ER visit, and 23.2 episodes managed at home over a 12-month period. Pain variability is 
additionally illustrated in a self-report diary-based study that assessed pain characteristics in a 
sample of 24 children with SCD aged 8 to 12 years over a period of eight weeks (Valrie, Gil, 
Redding-Lallinger, & Daeschner, 2007). The results showed children reported experiencing pain 
an average of 21.31% of the total diary days and an average pain severity rating on pain days of 
49.83 (on a 0 to 100 mm VAS scale). Another study of 25 youth with SCD aged 7 to 12 years 
and their caregivers reported on pain sites using the Varni/Thompson Pediatric Pain 
Questionnaire (Graumlich et al., 2001). The number of pain sites self-reported by children 
ranged from 1 to 6, while parents reported a range of 1 to 7. The most common site reported by 
parents and children was the leg, with other pain sites including the arm, knee, stomach, and 
back. To conclude, pain can be frequent, severe, and highly variable for SCD patients.  
Youth and young adult SCD pain has been connected to various poor outcomes. For 
example, one home-based daily diary study of 19 youth with SCD, aged 8 to 17 years, 
investigated the relation between pain and school performance across a total of 4,756 days 
(Shapiro et al., 1995). Youth were absent on 21% of the 3,186 school days, with half of the total 
absent days being as a result of severe pain. The study concluded that severe pain is linked to 
lower school attendance, which likely leads to poorer school performance. Another, daily diary-
based study of 37 youth with SCD aged 13 to 17 years investigated the relation between pain 
intensity and a range of outcomes (Gil et al., 2003). The study found that higher ratings of SCD 
pain were significantly associated with same day activity (e.g., more school absences, reduced 
extracurricular activities, less household chores) and health care use (e.g. more ER visits). 
Results also indicated that high pain intensity was associated with high same day stress and 
negative mood, and low pain intensity was associated with high same day positive mood. Youth 
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SCD pain is also the most common reason for frequent hospital trips in the population (Benton, 
Boyd, Ifeagwu, Feldtmose, & Smith-Whitley, 2011). Lastly, a study of 40 individuals with SCD 
aged 12 through 19 found that during pain crises, all domains of health-related quality of life 
were reported as being diminished. With pain being the hallmark feature of SCD disease (Benton 
et al., 2011), these findings illustrate the importance of fully understanding the factors and 
mechanisms associated with the experience of pediatric SCD pain. 
From a developmental perspective, the pain experience changes across the lifespan for 
individuals with SCD. A relationship between pain frequency and age has been established, with 
a multisite, longitudinal study finding a gradual increase of pain frequency until the age of 30 
(Platt et al., 1991). Further, findings from this study showed that pain rates for individuals with 
SCD aged 20 to 29 years were significantly higher than for individuals aged 0 to 9 years. For 
individuals under the age of 20, pain rates were significantly higher in those aged 10 to 19 years 
compared to those aged 0 to 9 years. Collectively, these results indicate that during the 
developmental periods of adolescence (i.e., 12 to 18 years) into emerging adulthood (i.e., 18 to 
25 years), individuals experience increasingly more frequent pain. These findings are further 
illustrated in another study that investigated rates of acute care utilization and re-hospitalizations 
for 21,112 patients aged 1 to 65 years and older with SCD using Healthcare Cost and Utilization 
Project State Inpatient Databases and State Emergency Department Databases (Brousseau, 
Owens, Mosso, Panepinto, & Steiner, 2010). They found that young adults aged 18 to 30 years 
had increased emergency department usage due to pain crises and the highest rate of re-
hospitalizations compared to other sickle cell age groups. The authors suggested that this may be 




To conclude, pain is highly variable in SCD patients. Each individual with SCD will 
display different pain features in regard to intensity, frequency, location and duration (N. Y. C. 
Dampier et al., 2004; Graumlich et al., 2001; Schatz et al., 2015). The mechanisms behind this 
pain variability are highly complex (C. Dampier et al., 2017; Field et al., 2019). According to the 
biopsychosocial model, factors that influence pain may include psychological and social factors, 
such as ACES (Ballas et al., 2012). The following section will discuss how ACEs may be related 
to pain experienced by youth and young adults with SCD.  
ACEs and SCD Pain 
 There are no current studies assessing ACEs in relation to pain for individuals with SCD. 
In addition, there is limited research examining ACEs in other pain populations; however, 
preliminary studies suggest a link between ACEs and pain experiences. Results from a cross-
sectional study of 232 pregnant women aged of 30 to 31 years indicated that more ACEs was 
associated with a high number of pain sites and high pain intensities for women later in 
pregnancies (Drevin et al., 2015). Another study of 5,001 participants aged 15 to 55 years 
examined the association between reports of ACEs and painful medical conditions (Sachs‐
Ericsson et al., 2017). The study used ten-year longitudinal data that was obtained from the 
National Comorbidity Surveys. The first survey obtained reports of ACEs and a 10-year follow-
up survey assessed for painful medical conditions, such as chronic back and neck problems, 
severe headaches, arthritis, and other chronic pain. Results indicated that certain ACEs, such as 
verbal and sexual abuse and parental loss, were associated with a higher likelihood of reporting 
painful medical conditions. The most common painful medical condition reported was back and 
neck problems (25.9%), followed by arthritis or rheumatism (23%).   
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 Research on the role of ACEs in youth pain populations is also limited. A conceptual 
review that examined the relationship between ACEs and chronic pain in youth populations 
reported that there is currently little known in regard to this relationship and much more research 
is needed (E. S. Nelson et al., 2018; M. S. Nelson, Cunningham, & Kashikar-Zuck, 2017). The 
authors identified studies that had compelling preliminary evidence in beginning to establish the 
relationship between ACEs and chronic pain in youth. Specifically, the authors found three 
studies with findings that indicate children and adolescents (up the age of 20) with particular 
chronic pain conditions (e.g., abdominal pain, recurrent headache, fibromyalgia) generally report 
a higher number of ACEs in comparison to healthy cohorts. The first study explored patterns of 
physical comorbidity in 1,672 female youth aged 0 to 17 with PTSD (Seng, Graham-Bermann, 
Clark, McCarthy, & Ronis, 2005). Results found PTSD was associated with increased odds of 
adverse health conditions, such as pelvic pain and fibromyalgia. The second study of 10,464 
adolescents aged 12 to 20 years (Stensland et al., 2013) found significant associations between 
exposure to traumatic interpersonal events and recurrent headaches. Further, they found a dose-
response relationship, where an increase in exposure to traumatic events was associated with a 
higher prevalence of recurrent headaches. The third study assessed the relationship between 
stressful life events and somatic complaints in 172 adolescents aged 11 to 19 (Greene, Walker, 
Hickson, & Thompson, 1985). Results indicated that patients with recurrent pain for which there 
was no identifiable organic cause reported significantly higher life stress in comparison to 
patients that were being seen for a routine checkup, had an acute minor illness, or a stable 
chronic illness or pain with an identifiable organic cause.   
A few recently published studies have also supplied preliminary evidence for the 
relationship between ACEs and pain in youth and young adults (E. S. Nelson et al., 2018; You et 
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al., 2019). One investigated the relationship between ACEs and several chronic illnesses, 
including chronic pain conditions, in a sample of 141 individuals aged 9 to 19 years (E. S. 
Nelson et al., 2018). Researchers reported that over 80% of the sample with chronic pain 
reported at least one ACE in their lifetime. Another study investigated whether more adverse 
events would be a risk factor for common chronic pain conditions in a sample of 3,073 
undergraduates, with a mean age of 18.8 years (You et al., 2019). Results indicated that more 
adverse events were significantly associated with a 1.2 to a 1.3-fold increase in odds of having 
any chronic pain disorder (e.g., chronic back pain, headache, dysmenorrhea).  
Overall, preliminary research suggests a link between ACEs and pain in youth and young 
adults; however, more research is needed to validate this relationship.  Additionally, to further 
understand this relationship, it would be insightful to explore how the experience of childhood 
trauma relates to biopsychosocial mechanisms linked to pain in youth and young adults.  
Although mechanistic research is limited linking ACEs to pain, potential pathways have been 
proposed, such as inflammation. Investigating associations between ACE exposure and 
inflammation would provide the grounding for future mechanistic work.  The next sections will 
discuss inflammation in more detail as well as exploring its relation to SCD pain and ACEs.  
Inflammation  
 Inflammation is the immune’s system response to harmful stimuli, such as damaged cells, 
toxic compounds and pathogens (L. Chen et al., 2018). During this response, there are complex 
cellular and molecular interactions and events that occur internally in an attempt to remove 
harmful stimuli and initiate a healing process (Medzhitov, 2010). At a cellular level, the 
inflammatory response is made of a coordinated network of many cell types. Examples include 
lymphocytes (e.g., a type of white blood cell), monocytes, neutrophils, and many others (L. Chen 
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et al., 2018). This response contributes to restorative tissue homeostasis and resolution of acute 
inflammation. However, when the acute inflammatory response is unable to be resolved and the 
heighted inflammatory state remains, chronic inflammation and tissue damage may result.  
 Chronic inflammation acts as pathophysiological mechanism that underlies a variety of 
diseases, such as bowel and cardiovascular diseases, diabetes, cancer and arthritis (Libby, 2007). 
An outcome from acute inflammatory mechanisms failing to eliminate tissue injury leads to 
chronic inflammation, which promotes further tissue damage (L. Chen et al., 2018). Tissue 
damage stems from a coordination of inflammatory and vascular cell responses to the injury. 
Inflammation at a tissue level is characterized by redness, swelling, heat, pain, and loss of tissue 
function. The potential adverse effects of chronic inflammation depend on the initial stimulus 
(e.g., toxic compound, damaged cells) and the location within the body.  
Cytokines (i.e., chemical messengers that are crucial for intracellular reactions within the 
body) are used to assess inflammation and are crucial in inflammatory research. They act as 
reliable biomarkers (i.e., measurable substances in an organism) due to how circulating levels of 
cytokines are produced by activated immune cells, which subsequently leads to activation of 
other cells that results in the further synthesis of more cytokines associated with inflammation 
(Hänsel, Hong, Cámara, & Von Känel, 2010). Commonly used inflammatory biomarkers include 
interleukins (IL), interferons (IFN), and tumor necrosis factor (TNF). In addition to cytokines, an 
acute phase protein called C-reactive protein (CRP) is another well-established inflammatory 
biomarker.  
The biomarkers discussed above all play their own unique role in promoting 
inflammation in SCD as well as coordinating with one another. An example of this coordination 
is seen for cytokines IL-4 and IL-10. Both are released when the inflammatory state is high and 
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subsequently promote the release of other pro-inflammatory cytokines, such as IFN-γ and TNF-α 
(Hänsel et al., 2010). In addition, TNF-α acts as the main mediator of acute inflammatory 
responses. When plasma levels of TNF-α are high, the production of IL-6 increases, which then 
promotes the release of acute phase proteins involved in inflammation (Bandeira et al., 2014). 
Thus, it is important to measure levels of multiple biomarkers to fully understand the current 
inflammatory state. Notably, CRP, TNF-α, and IL-6 have been studied in relation to 
inflammatory levels and pain in patients with sickle cell (Francis & Haywood, 1992; Krishnan et 
al., 2010; Qari, Dier, & Mousa, 2012; Sarray et al., 2015). Additionally, those three biomarkers 
have been used in studies assessing inflammatory levels in relation to individuals who have 
experienced ACEs (A. Danese et al., 2009; Gouin et al., 2017; Kate Ryan Kuhlman et al., 2017). 
Thus, CRP, TNF-α, and IL-6 are some examples that can serve as biomarkers that can 
comprehensively examine inflammatory levels in both a physiological context (i.e., sickle cell 
and pain) and psychosocial context (i.e., ACEs).  
Overall, inflammation is a complex physiological response that begins as beneficial, but 
if unresolved, then negative consequences such as tissue damage may result. Inflammation is 
particularly important for understanding sickle cell pain, as inflammatory processes have been 
found to be key components of many SCD complications (Conran & Belcher, 2018). The 
following section will discuss these key components of inflammation in SCD, specifically in 
relation to pain.   
SCD Pain and Inflammation.  
Inflammation plays crucial roles in the pathophysiology of SCD (Hoppe, 2014). 
Specifically, pro-inflammatory conditions contribute to the occurrence of VOCs and subsequent 
tissue damage (Lidiane et al., 2016). The tissue damage as a result of VOCs then proceeds to 
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promote the release of inflammatory mediators that are responsible for initiating the transmission 
of pain sensations and enhancing the perception of pain (Qari et al., 2012). This illustrates a 
continuous inflammatory cycle where inflammation promotes VOCs and VOCs then promote 
inflammation. Additionally, a common complication for individuals with SCD is leukocytosis 
(Abramson & Melton, 2000). When leukocytosis occurs, there is an elevation in inflammatory 
cytokines, which may lead to higher levels of inflammatory cytokines and subsequently promote 
VOCs, tissue damage, and SCD pain (Hoppe, 2014).  
Inflammation has been found to be elevated in patients with SCD (Francis & Haywood, 
1992; Hibbert et al., 2005; Lanaro et al., 2009; Zhang, Xu, Manwani, & Frenette, 2016). For 
instance, a study of individuals aged 4 to 65 investigated the effect of hydroxyurea therapy (HU) 
on the release of inflammatory mediators (i.e., TNF-α, IL-8) across three groups: a healthy 
control group with 33 participants, a group of 50 steady-state SCD patients, and another steady-
state group of 26 SCD patients on HU (Lanaro et al., 2009). Participants were characterized as 
steady state if they were not in a crisis and had not received a blood transfusion in the previous 
three months. Results indicated that both SCD steady-state groups showed heightened TNF-α 
and IL-8 levels in comparison to healthy controls, concluding that inflammatory levels are 
elevated in individuals with SCD whether they are on HU or not. Additionally, participants on 
HU exhibited lower TNF-α levels, though not IL-8 levels, in comparison to the steady-state with 
no HU. A second study showed similar findings in 34 adults aged 19 to 37 with SCD when 
examining levels of TNF-α and IL-1(Francis & Haywood, 1992). Inflammatory markers were 
considered elevated by using the TNF standard (i.e., >60 pg/mL) and the IL-1 standard (i.e. > 75 
pg/mL). Results revealed elevated levels of TNF-α in at least one occasion (i.e., steady state or 
painful crisis) in 27 of the 34 participants. Additionally, results indicated elevated levels of IL-1 
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in at least one occasion in 6 of the 34 participants with SCD. Lastly, another study investigated 
differences in CRP between 12 children with SCD and 9 healthy controls (Hibbert et al., 2005). 
Results indicated that CRP was significantly elevated in children with SCD compared to the 
healthy controls. Taken together, the findings from these three studies demonstrate an overall 
elevation in inflammatory biomarkers among individuals with SCD.  
To conclude, findings indicate that inflammatory biomarkers are elevated in individuals 
with SCD in comparison to healthy controls. Inflammation has also been linked to VOCs, 
subsequent tissue damage, and a heightened perception of pain. Taken together, the 
consequences of inflammation and its role in pain support the need to understand what factors 
may contribute to elevated inflammation, such as ACEs. The following section will explore the 
relationship between ACEs and inflammation.   
ACEs and Inflammation  
 The experience of ACEs is associated with toxic stress, which is then connected to 
subsequent physiological consequences. These consequences are particularly illustrated in the 
immune system (Lagraauw, Kuiper, & Bot, 2015), where exposure from toxic stress alters 
immune systems responses such as inflammation. Early life adversity has diverse effects across 
neural, endocrine, metabolic, immune (e.g. inflammation) and gut microbial axes (Berens et al., 
2017; S. Nelson, Bento, & Enlow, 2021). Additionally, there is extensive literature on the 
relationship between adversity exposure and poor health outcomes, as discussed in the ACEs 
section. However, there is a gap of knowledge in the consideration of how early life adversity 
contributes to the risk of specific health outcomes. One pathway that has been suggested from a 
biological viewpoint as the potential biological factor relating ACEs to poor health outcomes is 
inflammation. There are various studies that have found overall elevated inflammatory 
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biomarker levels in adult participants who were exposed to ACEs (M. Chen & Lacey, 2018; 
Andrea Danese & McEwen, 2012; A. Danese et al., 2009; Andrea Danese, Pariante, Caspi, 
Taylor, & Poulton, 2007; Gouin et al., 2017; Tietjen, Khubchandani, Herial, & Shah, 2012). This 
elevation provides preliminary support that inflammation may serve as a pathway linking ACEs 
to poor health outcomes. Notably, ACEs have not been assessed in patients with sickle cell; thus, 
literature cited in this section will focus on the general population.  
Studies have found a correlation between exposure to ACEs and higher inflammatory 
levels (M. Chen & Lacey, 2018; Andrea Danese & McEwen, 2012; Andrea Danese et al., 2007; 
Tietjen et al., 2012). For instance, a longitudinal study of 972 participants followed from birth to 
the age of 32 found that participants who were exposed to childhood maltreatment and very high 
social isolation had a significant risk of elevated CRP levels (A. Danese et al., 2009). Another 
study of 174 adult participants found that exposure to multiple ACEs was associated with 
elevations in IL-6, but not CRP levels (Gouin et al., 2017). These studies exhibit an association 
between exposure to ACEs and elevations of inflammatory biomarkers in adult populations.  
 For youth populations, the relationship between ACEs and inflammation is not as 
solidified. Kuhlman and colleagues (2019) completed a systematic review and meta-analysis 
gathering studies that assessed the relationship between ACEs and inflammatory levels in 
pediatric populations. Findings from the review indicated that only 27 studies had been published 
assessing this relationship, with CRP (9 total studies) and IL-6 (7 total studies) being the only 
biomarkers measured consistently in five or more studies. Results indicated significant 
associations between early life adversity and high CRP levels, although IL-6 was not consistently 
related to early life adversity. Additionally, they found that the use of saliva in measuring IL-6 
and CRP was not as validated as using blood-based markers. Also, the relationship between early 
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life adversity and CRP was stronger in studies of infants and adolescents than studies of children 
during middle childhood. ACEs was assessed in a variety of ways with 37% child report, 40.7% 
caregiver report, 18.5% third party report, and 3.7% using a combination of reports. The sample 
characteristics varied significantly across studies, with small samples of 27 to large samples of 
2,232 being assessed as well as with age ranges from birth through 19.  The review findings 
highlighted the crucial need of more research being done in this field and the importance in 
understanding inflammation in youth populations who have been exposed to ACEs (Kate R. 
Kuhlman, Horn, Chiang, & Bower, 2019) 
 To summarize, it is well understood that early adversity negatively impacts various 
physiological systems, including the immune system and its responses (i.e., inflammation) 
(Berens et al., 2017). Researchers have found a relationship between exposure to ACEs and 
elevated inflammatory biomarkers in adult populations. The relationship between ACEs and 
inflammation in youth populations is preliminarily established. However, given that 
inflammation has been connected with both ACEs and pain, research is needed to explore the 
associations among ACEs, inflammation and SCD pain to inform future work.  
The Current Study 
 The current study examined the prevalence of ACEs exposure in adolescents and young 
adults with SCD, and investigated the relationships between ACEs, pain, and inflammation in the 
sample. Given the current research showing negative outcomes associated with inflammation and 
pain experienced in adolescents and young adults with SCD (Benton et al., 2011; Gil et al., 2003; 
Shapiro et al., 1995), this study explored cumulative and individual ACEs as potential factors 
relating to SCD pain and inflammation. Understanding how ACEs is associated with 
inflammation and SCD pain will allow providers to better understand which adolescents and 
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young adult patients are more at risk for experiencing worse pain and other SCD outcomes, and 
to establish more individualized intervention plans to improve their quality of life.  
Aims and Hypotheses 
 The current study had three primary aims:  
Aim 1 
  To assess ACEs in adolescents and young adults with SCD. This includes describing the 
prevalence of cumulative ACEs as well as frequencies of specific ACE items.  
Aim 2 
To examine associations between cumulative ACEs, an inflammatory biomarker (CRP), 
and pain in adolescents and young adults with SCD.  
Hypothesis 2a: I hypothesized cumulative ACEs will be positively associated with levels 
of CRP.   
Hypothesis 2b: I hypothesized cumulative ACEs will be associated with worse pain  
outcomes (i.e., more severe pain and high pain frequency). 
Aim 3  
To assess the relationships between individual ACEs and pain in adolescents and young 
adults with SCD.  
Hypothesis 3a: I hypothesized exposure to individual ACEs will be positively associated 
with levels of CRP.  
Hypothesis 3b: I hypothesized exposure to individual ACEs will be associated with  







 Adolescents and young adults with SCD and the youth’s accompanying guardians were 
recruited from both the pediatric SCD clinic in the Children’s Hospital of Richmond and the 
adult SCD clinic at Virginia Commonwealth University (VCU). Inclusion criteria included being 
aged 12 to 25 years, having a diagnosis of SCD, and speaking fluent English. Exclusion criteria 
included the inability to complete surveys as decided by health care provider, having a comorbid 
pain condition (e.g., arthritis), experiencing an active pain crisis at the time of study recruitment, 
or receiving chronic blood transfusions.  
Procedure 
After the Institutional Review Board approved the study, potential participants and their 
guardians were approached during their regular outpatient visit at the Children’s Hospital of 
Richmond and the adult SCD clinics at VCU. Potential youth and young adult participants and 
the accompanying guardians of the youth were informed of the study and its procedure. If they 
were interested, young adults with SCD and guardians of youth with SCD completed informed 
consent forms, and youth completed assent forms. Consent included HIPAA authorization to 
review youth and young adult participants’ medical records and access participants’ bloodwork. 
The young adult participants and guardians of youth participants reported young adults’ and 
youth’s demographic and disease information. Youth and young adults reported their pain 
severity and frequency as well as their exposure to ACEs. Youth and young adults also had their 






Demographics and Disease Information. Youth and young adult’s age in years, SCD 
genotype and sex (coded as 1=female and 0=male) were collected through guardian and young 
adult interview and confirmed using the participant with SCD’s medical electronic record. SCD 
genotype was coded as 1=severe genotypes (e.g., HbSS and HbS/β0), and 0=moderate genotypes 
(e.g. HbSC and HbSβ+, or other). 
Adverse Childhood Experiences (ACEs) Questionnaire. The NSCH-ACE measure (C. 
D. Bethell et al., 2017) were used to assess ACEs with a total of nine items (see appendix) and 
were completed by youth and young adults. In the original NSCH ACE scale, there was one item 
involving discrimination due to race. This item was replaced with two items examining 
discrimination due to race in and outside of healthcare settings. Also, two items were added 
focused on discrimination due to SCD inside and outside of health care.  For the purposes of 
creating the cumulative measure of ACEs, the two items on discrimination due to race were 
collapsed into one item where a participant who responded yes to any of the two race 
discrimination questions was considered one ACE. The items referring to SCD were excluded 
from the calculation of the cumulative ACEs score but examined when looking at individual 
ACE items. Thus, the cumulative ACE score was consistent with the original NSCH ACE scale 
from 0 to 9. This was done to remain consistent with the NSCH-ACE measure, while also 
exploring new ACE items that may be particularly salient among youth and young adults with 
SCD. Further, consistent with NSCH-ACE scoring, for the SES related item responses of either 
“somewhat often” or “very often” were counted as one ACE. The original measure was parental 
report and thus, for youth and young adults, the wording of the directions was modified. The 
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NSCH-ACE measure has been shown to have efficiency, strong internal validity and high 
acceptability (C. D. Bethell et al., 2017).   
 Inflammatory Biomarker - CRP. CRP was collected via blood samples drawn by 
nurses from routine clinic visits and were processed by VCU Pathology. The residual material 
from the routine blood draw were used for the study and measured with the 
Immunochemiluminometric assay (ICMA) (Shiesh, Chou, Lin, & Kao, 2006). The “normal” 
range for CRP is less than 10 mg/L (Windgassen, Funtowicz, Lunsford, Harris, & Mulvagh, 
2011).  
Pain Severity and Frequency. The Structured Pain Interview (Gil et al., 2001) was 
completed by youth and young adults to assess their pain severity and pain frequency. Pain 
frequency was measured via the report of the number of pain episodes youth and young adults 
experienced in the past 6 months. Pain severity was measured using the question, “on average 
how would you rate the severity of your painful episodes during the past 6 months” and having 
them respond on a scale of 0 through 10 (i.e., 0 being no pain and 10 being severe pain). 
Reliability and validity of the Structured Pain Interview has been exhibited in other studies with 
youth with SCD (Gil et al., 1993; Gil, Williams, Thompson, & Kinney, 1991).   
Data Analysis Plan 
Post-Hoc Analysis 
Due to the low sample size, which was originally not anticipated, a post hoc power 
analysis was conducted using G*Power software to determine the current power with a sample 
size of 21(Faul, Erdfelder, Buchner, & Lang, 2009). The current power for correlation analyses 
with a power > 0.8 and alpha < 0.05 was 0.40.  
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Given how the p-value is dependent on sample size, the current study also focused on 
interpretations using Cohens’ effect size estimates (2013), as they are independent of sample size 
and thus will allow for more reliable estimates of the study’s results. Cohens’ d is a quantitative 
measure of the magnitude of the relationship between two variables, hence the larger the effect 
size, the stronger the relationship it is. The cutoffs for Cohen’s d used for interpreting 
comparison between two group on a continuous outcome are the following: a: 0.2 to 0.5 small 
effect size; b: 0.5 to 0.8 medium effect size; and c: > 0.8 large effect size. The cutoffs for 
Cohen’s interpretation of correlations (i.e., assessing the magnitude of the association between 
two continuous variables), are the following: a:  0.1 to 0.3 small association; b: 0.3 to 0.5 
medium association; and c: > 0.5 large association.   
Descriptive Statistics and Preliminary Analyses Plan  
 The R software program was used for analyses. Descriptive statistics in the overall 
sample were reported for study variables and sample characteristics. Specifically, cumulative 
ACEs, CRP, pain severity, pain frequency, and age were described with means, standard 
deviations, and ranges. Additionally, individual ACEs, sex, and genotype severity were 
described with frequencies. Further, descriptive statistics were calculated for the subsample of 
participants with CRP reports. Prior to all analysis, data distributions were examined for 
normality and outliers for cumulative ACEs, CRP, pain severity and pain frequency.    
Primary Analysis Plan  
Study Aim 1 analyses included descriptive statistics for cumulative ACEs (i.e., ranges, 
mean, SDs). Further, percentages of each ACE using frequency tables were calculated to 
determine distribution of ACE types reported.  
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Study Aim 2 analyses included calculating correlations between cumulative ACEs, CRP, 
and pain outcomes (i.e., pain severity and frequency). If cumulative ACEs were statistically 
associated with outcome variables (e.g., CRP, pain severity, pain frequency), regression models 
were calculated with cumulative ACEs as the predictor and CRP, pain severity, and/or pain 
frequency as outcomes.  Control variables included age, sex and SCD genotype severity. These 
covariates were selected in view of prior evidence finding higher age, being female and having a 
severe SCD genotype may put individuals with SCD at an increased risk for poor pain outcomes 
(Masese et al., 2021; Platt et al., 1991).   
Study Aim 3 analyses included independent sample t-tests and calculation of Cohen’s d 
for the relationship between each individual ACE and study outcomes (i.e., CRP, pain severity 
and frequency). Regression models would be run if more than one individual ACE was 
significant in t-test results to examine their unique relationship with inflammation and pain 
outcomes over and above the other ACEs. Control variables would include age, sex and SCD 
genotype severity.  
Results  
Descriptive Statistics   
Descriptive information for study variables is presented in Table 1. There were 21 
participants in the total sample, and 7 participants in the subsample had CRP reports. The 
average age of participants was 17.57 years, and the majority of the participants were female 
(71%) and diagnosed with a severe SCD genotype (67%). Fourteen of the participants (67%) 
reported experiencing a SCD pain episode in the last year. The average cumulative ACEs 
reported in the sample was 2.05 (Range = 0 to 6). Approximately 19% of the sample reported no 
ACE exposure, 9% of the sample reported one ACE, 43% reported two ACEs, and 29% reported 
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three or more ACEs (see Figure 1). In relation to pain, the average for pain severity was 8.07 on 
a 10-point scale (Range= 4 to 10) and for pain frequency was 78.86 episodes per year (Range = 1 
to 35). The average CRP level was 6.61 mg/L (0.4 to 30.7 mg/L). In total, there were seven 
reports of CRP, with only one participant having a CRP level above normal range (i.e., greater 
than 10 mg/L).  
Table 1. Sample characteristics  
Continuous Descriptives M SD Range n 
Age 17.57 4.43 12 to 25 21 
Cumulative ACEs 2.05 1.50 0 to 6 21 
Pain Severitya  8.07 1.90 4 to 10 14 
Pain Frequencya  8.86 11.2 1 to 35 14 
CRP 6.61 10.87 0.4 to 30.7 7 
Categorical Descriptives  n       % N  
Pain 14 67% 21  
Sex 
     Female 
     Male 
Genotype Severity  
    Severe 
    Non-severe  
    
15 71% 21  
6 29% 21  
    
14 67% 21  
7 33% 21  















Figure 1. Distribution of ACEs  
 
Note. ACEs= Adverse Childhood Experiences 
 
Cumulative ACEs, CRP, pain frequency and pain severity were assessed for normality 
through examining skewness and kurtosis statistics. All study variables were considered normal 
as absolute values for skewness and kurtosis in each variable fell within the range of +1 to -1.  
Primary Analyses  
 Prevalence and Distribution of Individual ACEs. Aim 1 assessed the prevalence of 
ACEs using ranges, mean and SD for cumulative ACEs and frequencies for individual ACEs.  
The average cumulative ACEs reported in the sample was 2.05 (SD = 1.5; Range = 0 to 6). For 
ACE prevalence, approximately 48% percent of the sample reported exposure to divorce (n=10), 
followed by 42% percent to financial instability (n=8), 33% to discrimination outside healthcare 
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with a mental illness (n=5). (See Figure 2 for full distribution of ACEs.) Conversely, there was 
low prevalence of exposure to parental death, witnessing both domestic and neighborhood 
violence, parental drug use/abuse, and discrimination due to SCD. Notably, for the individual 
discrimination items, experiencing discrimination outside of healthcare due to race (n=7) was 
more prevalent then reports of experiencing discrimination inside healthcare due to race (n=2) as 
well as discrimination due to SCD both inside (n=2) and outside healthcare (n=3). 
Figure 2. Rates of individual reported ACEs 
 

































































































































ACEs and Pain 
Cumulative ACEs and pain.  Aim 2 examined associations between cumulative ACEs 
and pain outcomes using Pearson correlations, including both interpretations of effect sizes and 
p-values. Due to the small sample size and lack of statistical power for running regression 
models, no controls were included in the analyses. According to Cohen (2013), correlations 
between 0.1 to 0.3 indicate a small association, between 0.3 to 0.5 indicate a moderate 
association, and 0.5 or higher indicates a large association. None of the correlational analyses 
between ACEs and pain were statistically significant. However, using Cohen’s interpretation of 
effect sizes, there was a small negative association between cumulative ACEs and pain 
frequency (r = -0.28, p = 0.32) (see Table 2).  
Table 2. Pearson Correlations Between Study Variables  
 1. 2. 3. 4. 
1.Cumulative ACE _    
2. Pain Severity  0.04 (0.88) _   
3. Pain Frequency  - 0.28 a (0.32)  - 0.24 (0.41) _  
4. CRP - 0.02 (0.96) - 0.75 c (0.46) - 0.08 (0.95) _ 
Note. Parentheses indicate p-value; Cohen Effect Size: a:  0.1 to 0.3 small association; b: 0.3 to 
0.5 medium association; c: > 0.5 large association  
 
Individual ACEs and Pain. Aim 3 assessed the relationships between individual ACEs 
and pain outcomes using independent sample t-tests. T-tests were run to determine if there were 
differences in pain severity and pain frequency based on exposure to an individual ACE. Since 
there were low frequency of several ACE items, I chose to analyze the top three most frequently 
reported ACEs as described in Aim 1 (i.e., financial instability, discrimination outside of 
healthcare due to race, and divorce). There were significant differences in pain severity based on 


















Pain Severity  
     Financial Instability  9.14 7.00 -2.50 0.02* -1.34c 
     Divorce 7.13 9.33 2.58 0.02* 1.39c 
     Discrimination outside 
HC due      
     to RACE  
6.80 8.78 2.10 0.06 1.17c 
 
Pain Frequency 
     Financial Instability  9.29 8.44 -0.14 0.89 -0.07 
     Divorce 7.75 10.33 0.41 0.69 0.22a 
     Discrimination outside 
HC due     
     to RACE  
9.40 8.55 -0.13 0.90 -0.07 
Note. * = p < .05; Cohen d Effect Size: a:  0.2 to 0.5 small effect size; b: 0.5 to 0.8 medium 
effect size; c: > 0.8 large effect size 
 
Acording to Cohen’s d, there was a large negative relationship between financial instability and 
pain severity (d = -1.34). Specifically, participants with no exposure to financial instability had 
lower pain severity (M = 7.00) compared to those with financial instability exposure (M = 9.14). 
For divorce and pain severity, there was a large positive relationship between divorce and pain 
severity (d = 1.39). Specifically, participants with no exposure to divorce had higher pain 
severity (M = 9.33) compared to those with divorce exposure (M= 7.13). For divorce and pain 
frequency, there was a small positive relationship between divorce and pain frequency (d = 
0.22). Specifically, participants with no exposure to divorce reported more pain frequency (M = 
10.33) compared to those reporting divorce exposure (M =7.75). For discrimination due to race 
outside healthcare and pain severity, there was a large positive relationship (d = 1.17). 
Participants with no exposure to discrimination reported more pain severity (M = 8.78), 
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compared to those reporting discrimination exposure (M =6.80).  For discrimination due to race 
outside healthcare and pain frequency, there was no relationship (d = -0.07). 
ACEs and Inflammation  
Cumulative ACEs and Inflammation. Aim 2 examined the association between 
cumulative ACEs and inflammation using a Pearson correlation, including both the interpretation 
of the effect sizes and p-value. Due to the small sample size and lack of statistical power for 
running regression models, no controls were included in the analyses. The correlational analysis 
between cumulative ACEs and inflammation had no relation and was not statistically significant 
(see Table 2).  
Individual ACEs and Inflammation. The descriptives for the subsample of the seven 
participants with CRP reports are the following: average age of 17.29 years (Range 13 to 24), 
pain frequency of 7.67 (Range 1 to 20), pain severity of 8.33 (Range 6 to 10), and cumulative 
ACEs of 1.71 (Range 0 to 4). Based on t-tests, there were no significant differences in age, pain 
outcomes, or cumulative ACEs between the CRP subsample and the overall sample. Further, 
approximately 86% of the CRP subsample was female and had a severe SCD genotype. Based on 
chi-square tests, there were no significant sex or SCD genotype differences between the CRP 
subsample and the overall sample.  
Aim 3 assessed the relationships between individual ACEs and CRP using independent 
sample t-tests. T-tests were run to determine if there were differences in CRP based on exposure 
to an individual ACE (i.e., financial instability, divorce, discrimination outside healthcare due to 
race). There were no statistically significant differences in CRP levels based on exposure to 


















 1.92 13.31 0.84 0.45 0.72b 
Divorce 
 1.59 13.31 1.58 0.18 1.20c 
Discrimination outside HC due to race  
 11.62 2.86 -1.07 0.33 -0.82c 
Note. Cohen d Effect Size: a:  0.2 to 0.5 small effect size; b: 0.5 to 0.8 medium effect size; c: > 
0.8 large effect size 
 
However, according to Cohen’s d (i.e., 0.2 to 0.5 small; b: 0.5 to 0.8 moderate; c: > 0.8 
large), there was a moderate positive relationship between financial instability and CRP (d = 
0.72). Specifically, participants with no exposure to financial instability had higher CRP levels 
(M = 13.31) compared to those reporting financial instability exposure (M= 1.92). For divorce, 
there was however a large positive relationship between divorce and CRP (d = 1.20). 
Specifically, participants with no exposure to divorce had higher CRP levels (M = 13.31) 
compared to those with divorce exposure (M= 1.59).   For discrimination outside healthcare due 
to race there was large negative relationship between discrimination outside healthcare due to 
race and CRP (d = 0.82). Specifically, participants with no exposure to discrimination outside 
healthcare due to race had lower CRP levels (M= 2.86), compared to those with discrimination 





 Previous research has indicated ACEs are related to worse pain in pediatric populations 
(Groenewald, Murray, & Palermo, 2020). Prior studies have also found a relationship between 
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ACE exposure and elevated inflammation in adult populations (Berens et al., 2017; Andrea 
Danese & McEwen, 2012), with preliminary support in pediatric populations as well (Kate R. 
Kuhlman et al., 2019). However, no prior research has been done to assess the relations of ACEs 
to pain and inflammation within a SCD population. This is of particular concern as pain in SCD 
is a significant complication connected to a host of poor health outcomes and poor quality of life 
(L. S. Sil, L. L. Cohen, & L. C. Dampier, 2016; Smith et al., 2008). Moreover, inflammation 
plays a critical role in the pathophysiology of SCD and is linked to a host of clinical 
complications, including pain (Hoppe, 2014). Thus, the overall goals of the current study were to 
describe the prevalence of ACES in adolescents and young adults with SCD, and to examine the 
relationships between ACEs, inflammation, and pain in this population.   
ACEs Prevalence and Distribution  
Cumulative ACEs were assessed using the NSCH-ACE measure original score of 0 to 9. 
Of note, the discrimination due to SCD both inside and outside of healthcare items were not 
included in the cumulative ACE measure and the and the discrimination due to race inside and 
outside of healthcare items were collapsed to maintain consistent scoring of the original NSCH-
ACE measure. The majority of participants in the current sample reported exposure to at least 
one ACEs (80%). This prevalence contrasts with data from the National Survey of Children's 
Health (NSCH) using the NSCH-ACE measure, which found approximately 49.8% of children 
reporting at least one ACE (Groenewald et al., 2020), and a study of college students that found 
51.7% of the sample reported at least one ACE (Grigsby et al., 2020). The most frequently 
reported ACEs in the sample were divorce (48%), racial discrimination outside healthcare 
settings (33%) and financial instability (42%). These patterns are consistent with a study 
examining ACE type prevalence using the NSCH data (Crouch, Probst, Radcliff, Bennett, & 
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McKinney, 2019), with the most frequently reported being economic hardship (22.5%) and 
parental divorce (21.9%). Conversely, only 3.3% of this national representative sample reported 
being treated unfairly due to race. Of note, in the 2018-2019 NSCH data, the prevalence of the 
discrimination due to race item among Black youth was 10.6% (Child Adolescent Health 
Measurement Initiative, 2021). This in contrast to prevalence estimates of 1.3% reported by 
White youth, 5.5% reported by Hispanic youth and 8.0% reported by Other. Thus, given how 
SCD impacts primarily Black individuals, this high prevalence of racial discrimination within the 
NSCH Black sample of youth, is consistent with the high prevalence found in the current sample. 
Of note, 33% of the current sample reporting exposure to discrimination due to race outside of 
healthcare is substantially higher than the 10.6% found in the NSCH Black sample, suggesting 
an increased risk of exposure to racial discrimination within pediatric sickle cell populations. 
Although the current sample size is small, this provides preliminary support that individuals with 
SCD may experience more ACEs than the general population as well as the general Black 
population. A potential explanation for elevated ACEs in a SCD population, may involve racial 
inequities, as SCD impacts primarily Black individuals. A national population study found 
higher ACE exposures reported by participants who identified as Black, Hispanic, or multiracial 
compared to White participants (Merrick, Ford, Ports, & Guinn, 2018). These findings are 
consistent with previous research indicating individuals with SCD are more likely to experience 
socioeconomic hardship and face stigma associated with their diagnosis of SCD (Lee, Smith-
Whitley, Banks, & Puckrein, 2019). 
The high parental divorce rate in the current sample is also consistent with Crouch (2019) 
findings of Non-Hispanic Black children were more likely to be exposed to parental divorce than 
their counterparts – 34.7% among Black children, 26% among Latinx children, and 22% among 
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White children (Maguire-Jack, Lanier, & Lombardi, 2020). Further, given these study findings 
and how approximately half of the study sample reported exposure to parental divorce, 
individuals with SCD may experience higher exposure rates than the general Black population as 
well. Lastly, an additional reason for such high parental divorce rates may involve the 
management of sickle cell and its impact on family functioning. Parents often assume the 
primary responsibility of managing their child’s disease management. This often results in 
considerable stress and thus may negatively impact the parents’ relationships (Sil, Woodward, 
Johnson, Dampier, & Cohen, 2021).  
The second most frequently reported ACE type was discrimination outside healthcare 
settings due to race. This is consistent with numerous studies finding Black youth face racial 
discrimination more frequently than the general population (Cheng, Cohen, & Goodman, 2015; 
Umaña-Taylor, 2016). For example, one study found approximately 90% of Black youth 
reporting they had experienced at least one discriminatory experience in the past year (Seaton, 
Caldwell, Sellers, & Jackson, 2008). Further, parents of Black youth were more likely to endorse 
the NSCH ACE item “treated unfairly due to race or ethnicity” compared to parents of White, 
Hispanic, and Other youth in the NSCH data (Child Adolescent Health Measurement Initiative, 
2021). Moreover, a systematic review found evidence that individuals with SCD face are at high 
risk of experiencing racial discrimination (Bulgin, Tanabe, & Jenerette, 2018). Lastly, 
individuals with SCD and their families often face financial hardship and lack of resources, 
which may contribute to the 33% of the current participants reporting financial hardship 
(Barbarin, Whitten, Bond, & Conner-Warren, 1999a). 
 Taken together, our results suggest that cumulative ACE exposure may be higher within a 
SCD population compared to the general population as well as the general Black population. 
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Furthermore, our results indicate that divorce, discrimination due to race, and financial hardship 
may be particularly prevalent experiences for youth and young adults with SCD. Future research 
is needed using a larger sample of individuals with SCD to validate these findings. 
Relation between ACEs and Pain   
Cumulative ACEs. The associations between cumulative ACEs and pain indicators were 
not statistically significant. However, there was a small negative association between cumulative 
ACEs and pain frequency – more ACEs was associated with fewer pain episodes per year. These 
findings were inconsistent with the hypothesis that more ACEs would be related to more 
frequent pain. It may be that examining ACEs as cumulative is not a good strategy for 
understanding the relationship between ACEs and SCD pain. It may be that individual ACEs 
differentially relate to pain, rather than cumulative ACEs. This is supported by a study of 48,567 
youth aged 6 to 17 that found certain ACEs were more robustly associated with risk for chronic 
pain compared to other ACE types (Groenewald et al., 2020). Specifically, children who were 
exposed to living with a mentally ill person or those exposed to financial instability were more 
likely to have chronic pain compared to children exposed to parental divorce or parental death. 
As discussed more in detail in the next section, these findings suggest ACE types may have 
distinctive relations with pain presentation. Given that a cumulative ACE measure does not 
account for the strength of each adverse experience (e.g., taking into consideration duration of 
adversity) (Dennis, Clohessy, Stone, Darnall, & Wilson, 2019) on pain, future work should 
attempt to replicate these findings within a larger sample size. By understanding the relation of 
cumulative ACEs to pain, health care providers may be able to establish more effective targeted 
interventions (Groenewald et al., 2020).   
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Individual ACEs. Although there were few statistically significant differences in pain 
outcomes based on financial hardship, divorce and racial discrimination, effect sizes indicated 
small to large associations between specific ACEs and pain. Consistent with our hypotheses, 
participants who reported exposure to financial instability had higher pain severity compared to 
those with no exposure. These findings are also consistent with a study that found increased 
chronic pain risk for children who report exposure to financial instability compared to other ACE 
types, such as divorce or parental death (Groenewald et al., 2020). In children with SCD, 
financial instability has also been associated with parental anxiety (Barbarin, Whitten, Bond, & 
Conner-Warren, 1999b) and a lack of medical care (Barbarin et al., 1999a). Notably, parental 
anxiety and fear have been related to an increase of functional disability risk and overall poorer 
functioning for children with SCD (Sil et al., 2021). Factors related to exposure of financial 
hardship in SCD (e.g., lack of medical care, parental functioning) may further explain the current 
study findings of strong associations between financial hardship and higher pain severity in 
youth with SCD as well as inform future interventions. For example, augmenting child focused 
interventions with parent focused interventions may buffer the relation of financial stability on 
higher pain severity.  Parent focused interventions may include parent support groups, parent 
mindfulness training or parental problem-solving skills (Sil et al., 2021).  
 Inconsistent with the hypotheses, participants who reported exposure to divorce had low 
pain severity and low pain frequency compared to those with no exposure. It may be that divorce 
is not an inherently negative experience for all children and may instead have positive effects for 
some and their families (Braver, Hipke, Ellman, & Sandler, 2004; Hetherington & Kelly, 2003). 
For example, numerous studies have found positive effects as a result of parental divorce, such 
as happier parents, less parental conflict (Halligan, Chang, & Knox, 2014), increased closeness 
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with siblings (Abbey & Dallos, 2004), and personal growth as a result of witnessing their 
parents’ emotions in a new way (Smart, 2006). In addition, exposure to divorce has differential 
impacts on children based on age exposed to divorce, with research indicating younger children 
are more negatively affected compared to older children and young adults (Kalter & Rembar, 
1981; Leon, 2003). As the current study sample consists of adolescents and young adults, this 
may have contributed to relations found between parental divorce and pain outcomes. Additional 
research is needed to examine relationships between parental divorce and pain outcomes for 
youth with SCD, with consideration of differential associations based on age of exposure to 
divorce.  
 Inconsistent with our hypothesis, participants who reported exposure to racial 
discrimination had less pain severity compared to those with no exposure. Further, there was no 
relationship between racial discrimination and pain frequency. This in contrast to a study of 
1,908 individuals aged 30 to 84 that found psychological distress due to perceived discrimination 
related to chronic pain development  (Brown et al., 2018). Another study in a nationally 
representative sample of children that found a strong association of exposure to racial 
discrimination and chronic pain risk (Groenewald et al., 2020). More research investigating the 
association between racial discrimination and pain is limited, particularly in pediatric 
populations. Additional research is needed to examine these inconsistent findings and investigate 
relationships between racial discrimination and pain outcomes for youth with SCD with a larger 
sample.  
 Collectively, the results found differential relations of pain outcomes based on ACE type. 
These findings underscore the need for future studies with larger sample sizes focused on 
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investigating the differential relationships between distinct ACEs and SCD pain outcomes in 
pediatric populations. 
Relations between ACEs and Inflammation  
Cumulative ACEs. Contrary to our hypotheses, in the subsample of 7 participants with 
CRP reports, cumulative ACEs was not associated with inflammation. Of note, the small sample 
size and the average CRP within the current study being the normal clinical range (< 10mg/L) 
may have impacted findings. Previous research findings have indicated that elevated CRP levels 
are related to pain outcomes (Krishnan et al., 2010; Mohammed, Mahdi, Sater, Al-Ola, & 
Almawi, 2010). Also, only one inflammatory biomarker, CRP, was collected, which limits our 
findings. Cumulative ACEs have been related to other inflammatory biomarkers, such as TNF-a 
and IL-1b, in other youth populations (Condon, 2018). It may be that cumulative ACEs within a 
SCD population are associated with inflammatory biomarkers beyond CRP. More research is 
needed to assess a range of inflammatory biomarkers and their relation to ACE exposure within a 
SCD population.  
Individual ACEs. Three specific ACEs – racial discrimination outside of healthcare, 
financial instability, and divorce – were examined in relation to inflammation. Although there 
were not statistically significant differences in inflammation based on exposure to the three 
specific ACEs examined, effect sizes indicated small to large associations between specific 
ACEs and inflammation. Consistent with our hypotheses, participants who reported exposure to 
racial discrimination outside of healthcare had higher CRP levels compared to those with no 
exposure. This is consistent with a systematic review suggesting a relationship between exposure 
racial discrimination in childhood, and systemic inflammation later in life (Cuevas et al., 2020). 
Of note, there are few studies examining the relation between exposure to discrimination and 
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inflammatory outcomes during childhood. The few studies however have found evidence of 
racial discrimination as associated with elevated CRP levels among Black youth (Brody, Yu, 
Miller, & Chen, 2015; Goosby, Malone, Richardson, Cheadle, & Williams, 2015). Given the 
current study findings of racial discrimination and SCD, future research should explore the 
relationships between various form of racial discrimination, including interpersonal or structural 
forms of racial discrimination (Simons et al., 2018), and inflammatory biomarkers in adolescent 
and young adult populations. Future studies may also want to investigate the extent to which 
interventions can reduce the association between inflammation and racial discrimination. 
Inconsistent with our hypothesis, participants who reported no exposure to financial 
instability had higher inflammation compared to those with exposure. This is in contrast with 
findings from other studies indicating financial hardship, instability, and low socioeconomic 
status are connected to immune system activation and subsequent elevated inflammation 
(Carmeli et al., 2020; Jensen, Berens, & Nelson, 2017). However, few studies have examined 
disadvantaged socioeconomic conditions in relation to inflammatory levels in youth populations 
(Carmeli et al., 2020). Also inconsistent with our hypothesis, participants who reported no 
exposure to divorce had higher CRP levels compared to those with exposure. There is limited 
literature investigating the individual effects of divorce on inflammation. However, the few 
studies in adult populations suggest parental divorce and separation are related to elevations of 
inflammation (Lacey, Kumari, & McMunn, 2013; Lacey, Pinto Pereira, Li, & Danese, 2020). 
Future research should investigate both financial hardship and divorce’s relation on 
inflammation within larger sample sizes of youth with SCD as well as incorporate a wider range 
of inflammatory biomarkers. As financial hardship and divorce differ in duration of exposure and 
divorce may have mixed effects (i.e., divorce may be perceived as positive when it reduces 
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parental conflict), it is possible inflammatory biomarkers are related to distinct ACE types based 
on those underlining features, such as timing, duration, and consequences (Lacey et al., 2020). 
Establishing specific adverse childhood experiences relation on inflammatory outcomes may 
allow future research to develop targeted interventions by identifying at risk youth with SCD to 
ultimately mitigate inflammatory sequelae throughout the lifespan.  
Overall, these findings suggest specific ACEs have differential relationships with 
inflammatory outcomes among youth with SCD. More research is needed to validate these 
findings concerning the relationships between specific ACEs and inflammation in youth with 
SCD.  
Additional Findings  
Inconsistent with prior investigations, there was a large negative association between 
inflammation and pain severity, such that low CRP was associated with more severe SCD pain. 
These findings are inconsistent with several studies finding elevated inflammation resulting in 
vaso-occlusive crises (i.e., acute pain crises) (Ballas et al., 2012; Conran & Belcher, 2018; 
Darbari, Sheehan, & Ballas, 2020; Hebbel, Osarogiagbon, & Kaul, 2004). The average CRP in 
the sample fell within normal (i.e., not clinical) range, which may explain these inconsistent 
findings as elevated CRP has been connected to acute pain crises. In addition, other 
inflammatory biomarkers including interleukins (e.g., IL-6) have been implicated in SCD pain 
severity (Qari et al., 2012). Thus, future research should examine these findings within a larger 
sample size as well as a incorporate a range of inflammatory biomarkers based on respective 




 Beyond the limitations mentioned above, it is important that the results of the study are 
viewed in the context of other limitations. Due to the small sample size, possible confounding 
factors – age, SCD genotype, and hydroxyurea use – were not included in the analyses. Given 
that pain increases as one ages (Platt et al., 1991), and pain tends to decrease when taking 
hydroxyurea (Wong, Brandow, Lim, & Lottenberg, 2014), it is imperative to understand the 
association of ACEs and SCD pain in the context of these possible confounding factors. Further, 
the majority of the sample was female, which may have impacted the study’s findings. This is 
consistent with other pediatric SCD samples in other studies, which have tended to have a higher 
percentage of female compared to male participants (Fisher et al., 2018; Graves & Jacob, 2014; 
Schatz et al., 2015; Sehlo & Kamfar, 2015; Sil et al., 2021; Valrie et al., 2019). This may suggest 
gender differences in recruitment and completion rates among youth with SCD. Given how prior 
investigations have found significant sex differences in both pain outcomes (Ilesanmi, 2013) and 
inflammation (Casimir, Mulier, Hanssens, Zylberberg, & Duchateau, 2010), future work should 
implement recruitment strategies targeted towards Black male youth for a more equal 
distribution of female and male participants.  
Further, the study used a cross-sectional design, making it correlational and unable to 
identify causal relationships. Thus, the results could not indicate whether ACE exposure caused 
worse inflammation and pain for adolescents and young adults with SCD. Future research should 
implement longitudinal designs examining the temporal relationship between ACEs, 
inflammation, and pain outcomes within a SCD population. Identifying a temporal relationship 
between ACEs, inflammation, and pain, would highlight the enduring effects of toxic stress and 
support the importance of prevention efforts to combat the impact of ACEs in reducing 
inflammation and pain risk across.  
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 Lastly, due to the sample size, we were unable to investigate whether inflammation 
mediated the relationships between ACEs and pediatric SCD pain. Mechanisms underlying the 
relationship between ACEs and pain remain unclear. Although there was not a significant 
correlation between cumulative ACEs and inflammation, there was a strong association between 
inflammation and worse SCD pain severity. Further, there were strong associations between 
specific ACEs and pain outcomes. Thus, future work with a larger sample size is needed to 
establish whether associations exist between both cumulative ACEs and ACE types with 
inflammation within a SCD population. This would then suggest a potential mediating effect of 
inflammation between ACEs and pain in SCD.  
Future Research Directions and Applied Implications 
The high prevalence of ACEs in our sample of adolescents and young adults with SCD 
supports the importance of future work investigating ACES prevalence in a larger sample of 
individuals with SCD. No prior studies have examined the prevalence of ACEs in a SCD 
population. Moreover, ACE questionnaires often exclude discrimination as an ACE type 
(Cronholm et al., 2015). However, consistent with the traditional ACEs (e.g., parental divorce, 
financial hardship), exposure to discrimination by individuals with SCD and other populations 
has been widely associated with negative health consequences Given the negative impact on 
health and the high prevalence of racial discrimination found in the current sample, it is critical 
for future studies to include this as an ACE item, particularly for SCD populations.  
Further, although there are studies investigating ACEs in other adolescent and young 
adult populations, this work may not be generalizable to a SCD population. In the United States, 
it is well-established that significant health disparities exist for those that are low-income, racial 
minorities, and publicly insured (Lee et al., 2019). Individuals with SCD and their families bear a 
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distinct and pronounced burden with these health disparities, as the majority of the patient 
population are Black, face financial hardship, and are publicly insured (DeBaun & Telfair, 
2012). In combination with the severity of the disease itself, these disparities exacerbate stress, 
may reduce one’s quality of life (Perry Caldwell & Killingsworth, 2021), and may leave a child 
with SCD at an increased risk of ACE exposure as well as an increased vulnerability to the 
effects of toxic stress as a result of adverse experiences. Thus, future work is critically needed to 
address ACEs within a SCD population and its impact on health and health-care outcomes.  
Further, investigating strength-based approaches to managing the possible effects of 
ACES, such as resilience, is a promising avenue for future work. Resilience is defined as the 
“capacity of a system to adapt successfully to challenges that threaten the function, survival or 
future development of the system” (Masten, 2011). Future work could investigate resilience as a 
factor mitigating the effects of individual ACEs on pain. Resilience is a particularly significant 
area for establishing interventions as its modifiable and a strength-based factor that entails 
practical and targeted interventions and has been applied toward improving pain related 
outcomes in other populations (Cousins, Kalapurakkel, Cohen, & Simons, 2015). Some 
examples of components in a resilience intervention are emotional regulation training, cognitive 
behavioral approaches, physical health information on exercise, nutrition, and social support . 
(Southwick & Charney, 2012). Interventions such as this provide a promising avenue to mitigate 
the impact of ACEs. In addition, psychological and behavioral based interventions may also 
reduce inflammation and provide a promising avenue for future intervention work. For example, 
one study found resilience resources (e.g., awareness of self and others, physical health 
behaviors), attenuated the association between ACEs and inflammation in a sample of adults 




 This study lays the groundwork for future studies on ACEs in individuals with SCD, and 
relationships between ACEs, inflammation, and pain outcomes in adolescents and young adults 
with SCD. Approximately half of the current sample reported exposure to at least one ACE, 
suggesting a high prevalence of ACE exposure within a youth SCD population. Cumulative 
ACEs did not relate to inflammation or pain. However, our findings do suggest ACE types relate 
distinctively to inflammation and pain outcomes, specifically financial hardship, racial 
discrimination, and divorce. The study findings support the importance of taking into 
consideration the differential impact of different adverse experience experiences and their 
relationships to inflammation and pain within a SCD population. These results have implications 
for informing the potential salience of interventions aimed at mitigating the physiological 
consequences of ACEs and in turn, an improvement of inflammation and pain outcomes. Further, 
findings highlight the critical need for future work to investigate factors that may attenuate the 
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NSCH-ACE Youth and Young Adult Measure 
 
1. SINCE YOU WERE BORN, how often has your family experienced a very hard time to 
get by on the family income- hard to cover the basics like food or housing? 
☐ Never 
☐ Rarely 
☐ Somewhat often 
☐ Very often  
  
The next questions are about events that may have happened during your life. These things 
can happen in any family, but some people may feel uncomfortable with these questions. 
You may skip any questions you do not want to answer.  
 
To the best of your knowledge, have you EVER experienced any of the following? 
 
2. Parent or guardian divorced or separated                                           ! yes ! no 
3. Parent or guardian died                                      ! yes ! no 
4. Parent or guardian served time in jail                                    ! yes ! no 
5. Saw or heard parents or adults slap, hit, kick, punch one another in the home    ! yes ! no 
6. Was a victim of violence or witnessed violence in neighborhood                           ! yes ! no 
7. Lived with anyone who was mentally ill, suicidal, or severely depressed.             ! yes ! no 
8. Lived with anyone who had a problem with alcohol or drugs                                 ! yes ! no 
9. Treated or judged unfairly because of his or her race or ethnic group 
a.  Inside of health care settings       ! yes ! no 
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b. Outside of health care settings     ! yes ! no 
 
10. Treated or judged unfairly because of you have sickle cell disease 
a. Inside of health care settings       ! yes ! no 
b. Outside of health care settings    ! yes ! no 








STRUCTURED PAIN INTERVIEW 
 
I. Pain   “Painful episode” = any episode of pain that you would attribute to SCD,  




How many painful episodes have you had in the past 6 months?  _______ 
 
B. Duration: 
How long do your painful episodes last in hours or days? 
_________________________(Indicate hours or days)  




Using the following 0-10 scale (0= no 
pain, 10 = pain as bad as you can 
imagine), on average, how would you 
rate the severity of your painful 
episodes, during the past 6 months? 
(Circle a number on the line) 
 
D. Unpleasantness:  
Using the following 0-10 scale (0 = 
not unpleasant, 10 = most unpleasant 
feeling possible), on average, how 
would you rate the unpleasantness of 
your painful episodes during the past 6 months?  




E. Location:  
Color in the areas on these drawings to 
show where you have pain. Make the 
marks as big or small as the place where 

















F.       In the past month:  
How many pain days have you had in the past month? ________ 
 
Circle the number of days you had pain per week in the past month?  
 
Everyday 
● 5 to 6 days per week 
● 3 to 4 days per week 
● 1 to 2 days per week 
● A few days per week 
● None 
 
How long have you experienced this current level of monthly pain 
frequency?____________________ (Indicate in months or years)  
 
G. Severity: (Past Month) 
Using the following 0-10 scale (0= no 
pain, 10 = pain as bad as you can 
imagine), on average, how would you 
rate the severity of your painful 
episodes, during the past month? (Circle 




H. Unpleasantness:  (Past Month) 
Using the following 0-10 scale (0 = 
not unpleasant, 10 = most unpleasant 
feeling possible), on average, how 
would you rate the unpleasantness of 
your painful episodes during the past month? (Circle a number on the line). 
 
I. Additional Signs of Pain 
When in pain, have you had any of these signs? (Check all that apply) 
_____ Palpation (i.e., pushing on) the region of the pain produces pain or tenderness 
_____ Movement of the region of pain produces pain 
_____ Decreased range of motion or weakness in the region of pain 
_____ Evidence of skin ulcer in the region of pain 
_____ Your doctor(s) has indicated evidence of hepatobiliary or splenic imaging 
abnormalities (e.g., splenic infarct, chronic pancreatitis) consistent with the 
region of pain 
_____ Your doctor(s) has indicated evidence of imaging abnormalities consistent with 
bone infarction or avascular necrosis in the region of pain 
 
Is there another diagnosis that better explains the signs and symptoms of your pain? 
(Check one) _____ No  
_____Yes, What? ________________________________ 
 
J. Severity: (Past Week) 
Using the following 0-10 scale (0= no 
pain, 10 = pain as bad as you can 
imagine), on average, how would you 
rate the severity of your painful 
episodes, during the past week? (Circle 
a number on the line) 
 
K. Unpleasantness: (Past Week) 
Using the following 0-10 scale (0 = 
not unpleasant, 10 = most unpleasant 
feeling possible), on average, how 
would you rate the unpleasantness of 
your painful episodes during the past week? (Circle a number on the line). 
 
II.  Health Care Utilization: 
        
A. Emergency Room Visits: 
How many times have you gone to the emergency room because of your pain in the past 




 B. Hospitalization: 
How many times have you been hospitalized because of pain in the past 6 
months?___________________ 
 
How long has each stay lasted on average? _________________________ 
 
C.         Doctor Visits or Calls:  
How many times have you gone to see a doctor or other healthcare professional because 
of pain in the past 6 months? ___________________________ 
 
L. Pain Medication: 
What over the counter analgesic medications (e.g. Tylenol, aspirin, or Motrin) do you 





What prescription narcotic analgesic medication (e.g. percodan, Demerol, Tylenol13 
codeine) do you take for pain? 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
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